NewsRx

Search our medical news database

Influenza Vaccine

CytoDyn announces progress with DNA pre-vaccines for influenza

Published in Vaccine Weekly, December 6th, 2006

CytoDyn, Inc. (CYDY) announced that optimization of the company's DNA-based pre-vaccines for influenza (the flu) will be reported in an upcoming issue of the Journal of Virology online.

The encouraging results of the optimization technique (known as "codone optimization") are described in a paper by S. Xang, J. Taffe, C. Parker, A. Solorzano, Hiong Cao, Adolfo Garcia-Sastre and Shan Lu, from The University of Massachusetts Medical School, Worcester, Massachusetts, and the Mount Sinai School of Medicine, New York, New York.

CytoDyn's Product Development Team is preparing to apply to the FDA for a pre-IND meeting next year to begin clinical...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook